Search Within

Philip Wayne Kantoff

Formats
  1. Journal Article (118)
  2. Meeting Abstract (71)
  3. Review (4)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Department of Medicine (198)
  2. Genitourinary Oncology Service (198)
  3. Solid Tumor Oncology Division (198)
  4. Sloan Kettering Institute Postdocs (71)
  5. GSK Faculty (26)
  6. Human Oncology and Pathogenesis Program (23)

More Groups

People
  1. Konrad Stopsack (44)
  2. Goutam Chakraborty (29)
  3. Ying Mazzu (29)
  4. Subhiksha Nandakumar (27)
  5. Michael Morris (26)
  6. Yuki Yoshikawa (23)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (19)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (17)
  3. Cancer Research (16)
  4. Cancer (9)
  5. Cancer Epidemiology Biomarkers and Prevention (8)
  6. European Urology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (62)
  2. American Association for Cancer Research (46)
  3. Nature Publishing Group (16)
  4. Oxford University Press (11)
  5. Wiley Blackwell (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Regulation of the tumor suppressor PLZF and prostate cancer prognosis
    Meeting Abstract

    Stopsack, K. H.; Gerke, T. A.; Tyekucheva, S.; Mucci, L. A.; Kantoff, P. W.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Immunotherapy for biochemically recurrent prostate cancer
    Meeting Abstract

    Madan, R. A.; Karzai, F.; Bilusic, M.; Strauss, J.; Slovin, S. F.; Harshman, L. C.; Theoret, M. R.; Arlen, P. M.; Rauckhorst, M.; Couvillon, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Early versus delayed initiation of salvage androgen deprivation therapy and the risk of prostate cancer-specific mortality
    Meeting Abstract

    Mahal, B. A. V.; Chen, M. H.; Renshaw, A. A.; Kantoff, P. W.; D'Amico, A. V.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Gerke, T. A.; Chakraborty, G.; Armenia, J.; Atiq, M. O.; Komura, K.; Yoshikawa, Y.; Lee, G. S. M.; Mucci, L. A.; Kantoff, P. W.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry
    Meeting Abstract

    Francini, E.; Gray, K. P.; Shaw, G.; Evan, C.; Hamid, A.; Perry, C. E.; Kantoff, P. W.; Taplin, M. E.; Sweeney, C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent deletion of BRCA2 and RB1 and aggressive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nanjangud, G.; Chadalavada, K.; Atiq, M. O.; Komura, K.; Yoshikawa, Y.; Khan, N.; Du, S. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Targeting poor-prognosis subtypes of prostate cancer by inhibition of DNA repair gene ribonucleotide reductase small subunit M2
    Meeting Abstract

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Gerke, T. A.; Coggins, S. A. A.; Qiu, X.; Atiq, M.; Stopsack, K. H.; Lee, G. S. M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Intratumoral CYP27A1 expression in relation to cholesterol synthesis and vitamin D signaling and its association with lethal prostate cancer
    Meeting Abstract

    Khan, N. A.; Stopsack, K. H.; Allott, E. H.; Gerke, T. A.; Giovannucci, E. L.; Mucci, L. A.; Kantoff, P. W.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • IMAAGEN study biomarker analysis in patients with long term response to abiraterone acetate with prednisone for non-metastatic castrate resistant prostate cancer
    Meeting Abstract

    Chornoguz, O.; Shen, D.; Kapoor, G.; Li, W.; Phillips, J.; Ryan, C. J.; Crawford, E. D.; Shore, N. D.; Underwood, W.; Taplin, M. E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Pharmacokinetic (PK) analysis of concurrent administration of enzalutamide (enza) and crizotinib (crizo) in patients with metastatic castration resistant prostate cancer (CRPC)
    Meeting Abstract

    Tripathi, A.; Supko, J. G.; Gray, K. P.; Melnick, Z.; Taplin, M. E.; Choudhury, A. D.; Pomerantz, M.; Bellmunt, J.; Yu, C.; Sun, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save